Eli Lilly Weight Loss Pill

New weight loss pill to be approved by early 2026

Eli Lilly CEO expects new weight loss pill to be approved next year

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.

Business Insider · 3d

Eli Lilly CEO tells Bloomberg TV company sees weight loss pill approval in 2026

Eli Lilly (LLY) expects that its experimental weight loss pill will get approved as soon as early next year, CEO David Ricks said in an

BayStreet · 2d

Eli Lilly Buys Cancer Therapy And Announces Timing Of Weight Loss Pill

Pharmaceutical giant Eli Lilly & Co. (LLY) is buying privately held Scorpion Therapeutics’ experimental cancer therapy for $2.5 billion U.S. in cash. Eli Lilly is purchasing Scorpion’s experimental oral therapy called “STX-478,

Yahoo Finance3d

Eli Lilly's weight loss pill could get federal approval by early next year

Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks told Bloomberg News on Monday that data on the drug, orforglipron ...

Oral Ozempic and a ‘miracle’ pill imitating the keto diet – a new era of weight loss is here

The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

The Next Web6d

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

Lilly oral obesity drug could get FDA okay in early 2026: report

CEO Dave Ricks said Monday that the company's weight-loss pill orforglipron could receive FDA approval as soon as early 2026. Read more here.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results